Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (51)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mathern, G. W.
Right arrow Articles by Peacock, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathern, G. W.
Right arrow Articles by Peacock, W. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol 120, Issue 11 1937-1959, Copyright © 1997 by Oxford University Press

ARTICLES

Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy patients

GW Mathern, JK Pretorius, HI Kornblum, D Mendoza, A Lozada, JP Leite, LM Chimelli, I Fried, AC Sakamoto, JA Assirati, MF Levesque, PD Adelson and WJ Peacock
Department of Neurology, University of California, USA.

This study was designed to determine whether hippocampal neuronal AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) and NMDA (N- methyl-D-aspartate) mRNA levels were differentially increased in temporal lobe epilepsy patients compared with those measured in control tissue from non-seizure autopsies. Hippocampi from hippocampal sclerosis patients (n = 28) and temporal mass lesion cases (n = 12) were compared with those from the autopsies (n = 4), and studied for AMPA GluR1-3 and NMDAR1-2 mRNAs using semi-quantitative in situ hybridization, along with fascia dentata and Ammon's horn neuron densities. Compared with the autopsies, and without correction for neuron counts, the mass lesion cases with neuron densities similar to autopsies showed: (i) significantly increased NMDAR2 hybridization densities for fascia dentata granule cells; (ii) increased AMPA GluR3 mRNA densities for Ammon's horn pyramids; and (iii) similar or numerically increased mRNAs for all other subunits and hippocampal subfields. Compared with the autopsies, hippocampal sclerosis cases with decreased neuron densities showed: (i) significantly decreased AMPA GluR1-2 and NMDAR1-2 hybridization densities for Ammon's horn pyramids and (ii) similar or numerically decreased mRNAs for all other subunits and subfields. However, correcting for changes in neuron densities showed that hippocampal sclerosis patients had increased AMPA and NMDA mRNA levels per neuron compared with autopsies, and in the CA2 resistant sector GluR2 mRNA levels were numerically greater than autopsies and mass lesion cases. Furthermore, relative to autopsies both sclerosis and mass lesion hippocampi showed that, in the stratum granulosum, the greatest mRNA increases were in AMPA GluR1 and NMDAR2 compared with the other mRNAs. In chronic temporal lobe seizure patients these results indicate that mass lesion and sclerosis cases show differential increases in hippocampal AMPA and NMDA mRNA levels per neuron compared with autopsies, especially for AMPA GluR1 and NMDAR2 in fascia dentata granule cells. These findings support the hypothesis that temporal lobe seizures are associated with increased ionotropic glutamate receptor mRNA levels and alterations in receptor subunit composition that probably contribute to neuronal hyperexcitability, synchronization and seizure generation.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
S. Gabriel, M. Njunting, J. K. Pomper, M. Merschhemke, E. R. G. Sanabria, A. Eilers, A. Kivi, M. Zeller, H.-J. Meencke, E. A. Cavalheiro, et al.
Stimulus and Potassium-Induced Epileptiform Activity in the Human Dentate Gyrus from Patients with and without Hippocampal Sclerosis
J. Neurosci., November 17, 2004; 24(46): 10416 - 10430.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
J. Yun, R. J. Gaivin, D. F. McCune, A. Boongird, R. S. Papay, Z. Ying, P. J. Gonzalez-Cabrera, I. Najm, and D. M. Perez
Gene expression profile of neurodegeneration induced by {alpha}1B-adrenergic receptor overactivity: NMDA/GABAA dysregulation and apoptosis
Brain, December 1, 2003; 126(12): 2667 - 2681.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
A. Castensson, L. Emilsson, P. Preece, and a. E. Jazin
High-resolution Quantification of Specific mRNA Levels in Human Brain Autopsies and Biopsies
Genome Res., August 1, 2000; 10(8): 1219 - 1229.
[Abstract] [Full Text]

Home page
 NeurologyHome page
D. C. Henshall, R. S. B. Clark, P. D. Adelson, M. Chen, S. C. Watkins, and R. P. Simon
Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy
Neurology, July 25, 2000; 55(2): 250 - 257.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
D. N Lieberman and I. Mody
Properties of single NMDA receptor channels in human dentate gyrus granule cells
J. Physiol., July 1, 1999; 518(1): 55 - 70.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
R. J. Delorenzo and T. A. Morris
{blacksquare} REVIEW : Long-Term Modulation of Gene Expression in Epilepsy
Neuroscientist, March 1, 1999; 5(2): 86 - 99.
[Abstract] [PDF]

Home page
 NeurologyHome page
G. W. Mathern, D. Mendoza, A. Lozada, J. K. Pretorius, Y. Dehnes, N. C. Danbolt, N. Nelson, J. P. Leite, L. Chimelli, D. E. Born, et al.
Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy
Neurology, February 1, 1999; 52(3): 453 - 453.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.